Epidemiological risk factors and clinicopathological presentation in chronic hepatitis C

Hepato-Gastroenterology

Volumn 45, Issue 23, 1998, Pages 1715-1721

  Lo Lacono, Oreste ^a   DeCastro, Mar ^a   Garcia Buey, Luisa ^a   Garcia Monzon, Carmelo ^a   Borque, Maria J ^a   Sanz, Paloma ^a   Garcia Sanchez, Asuncion ^a   Moreno Otero, Ricardo ^a,b  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

Author keywords

Antibodies to HCV; Chronic hepatitis C; Epidemiological risk factors; HCV RNA; Hepatitis C pathology; Hepatitis C virus

Indexed keywords

HEPATITIS C ANTIBODY; VIRUS RNA;

ACUPUNCTURE; ADULT; AGE; ARTICLE; BLOOD CHEMISTRY; BLOOD TRANSFUSION; CLINICAL FEATURE; DISEASE SEVERITY; FEMALE; HEMODIALYSIS; HEPATITIS C; HUMAN; INTRAVENOUS DRUG ABUSE; LIVER HISTOLOGY; MAJOR CLINICAL STUDY; MALE; OCCUPATIONAL DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; RISK FACTOR; SEX DIFFERENCE; SURGERY; TATTOO;

ADOLESCENT; ADULT; AGED; ANTIBODIES, VIRAL; FEMALE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; LIVER; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK FACTORS; RNA, VIRAL;

EID: 0031736946     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M: Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989, 244: 359-362.
2. Esteban JI, Esteban R, Viladomiu L, Lopez-Talavera JC, Gonzalez A, Hernandez JM, et al: Hepatitis C virus antibodies among risk groups in Spain. Lancet 1989, 2: 294-297.
3. Choo QL, Weiner AJ, Overly LR, Kuo G, Houghton M, Bradley DW: Hepatitis C virus: The major causative agent of viral non-A, non-B hepatitis. Br Med Bull 1990, 46: 423-441.
4. Gerber MA, Krawczynski K, Alter MJ, Sampliner RE, Margolis HS, Sentinel Counties Chronic Non-A, Non-B Hepatitis Study Team: Histopathology of community acquired chronic hepatitis C. Mod Pathol 1992, 5: 483-486.
5. Hasan F, Jeffers LJ, De Medina M, Reddy KR, Parker T, Schiff ER, et al. Hepatitis C-associated hepatocellular carcinoma. Hepatology 1990, 12: 589-591.
6. Sanchez-Tapias JM, Barrera JM, Costa J: Hepatitis C virus infection in patients with non-alcoholic chronic liver disease. Ann Intern Med 1990, 112:921-924.
7. Bruix J, Barrera JM, Calvet X, Ercilla G, Costa J, Sanchez-Tapias JM, et al. Prevalence of antibodies to hepatitis C virus in Spanish patients with hepato-cellular carcinoma and hepatic cirrhosis. Lancet 1989, 2:1004-1006.
8. Simonetti RG, Camma C, Fiorello F, Cottone M, Rapicetta M, Marino L, et al. Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. A case-control study. Ann Intern Med 1992, 116: 97-102.
9. Cristiano K, Di Bisceglie AM, Hoofnagle JH, Feinstone SM: Hepatitis C viral RNA in serum of patients with chronic non-A, non-B hepatitis: Detection by the polymerase chain teaction using multiple primer sets. Hepatology 1991, 14: 51-55.
10. DiBisceglie AM, Goodman ZD, Ishak KG, Hoofnagle JH, Melpolder JJ, Alter HJ: Long-term clinical and histopathological follow-up of chronic post-transfusion hepatitis. Hepatology 1991, 14:969-974.
11. Seeff LB, Buskell-Bales Z, Wright EC, Durako SJ, Alter HJ, Iber FL, et al. Long-term mortality after transfusion associated non-A, non-B hepatitis. N Engl J Med 1992, 327:1906-1911.
12. Koretz RL, Abbey H.Colepman E, Gitnitk G: Non-A, non-B post-transfusion hepatitis. Looking back in the second decade. Ann Intern Med 1993, 119:110-115.
13. Munoz-Gomez R, Garcia-Monzon C, Garcia-Buey L, Lo Iacono O, Borque MJ, Garcia-Sanchez A, et al. Hepatitis C virus infection in Spanish volunteer blood donors: HCV RNA analysis and liver disease. Eur J Gastroenterol Hepatol 1996, 8: 273-277.
14. Garcia-Bengoechea M, Emparanza JI, Sarriugarte A, Cortes A, Vega JL, Gonzales F, et al. Antibodies to hepatitis C virus: A cross-sectional study in patients attending a trauma unit or admitted to hospital for elective surgery. Eur J Gastroenterol Hepatol 1995, 7:237-241.
15. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981, 1: 431-435.
16. Alter MJ, Margolis HS, Krawczynski K, Judson FN, Maresa, Alexander WJ, et al. The natural history of community-acquired hepatitis C in the United States. N Engl J Med 1992, 327:1899-1905.
17. Alter MJ, Hadler SC, Judson FN, Mares A, Alexander J, Hu PY, et al. Risk factors for acute non-A, non-B hepatitis in the United States and association with hepatitis C virus infection. JAMA 1990, 264:2231-2235.
18. Weiner AJ, Kuo G, Bradly DW, Bonino F, Saracco G, Lee C, et al. Direct detection of the hepatitis C viral sequences in anti-HCV antibody positive and negative individuals with post-transfusion non-A, non-B hepatitis. Lancet 1990, 335:1-3.
19. Alter MJ: Inapparent transmission of hepatitis C: Footprints in the sand. Hepatology 1991, 14:389-391.
20. Brown J, Dourakis S, Karayiannis P, Goldin R, Chiba J, Chiba H, et al. Seroprevalence of hepatitis C virus nucleocapsid antibodies in patients with cryptogenetic chronic liver disease. Hepatology 1992, 15:175-179.
21. Dienstag JL, Alter HJ: Non-A, non-B hepatitis: evolving epidemiological and clinical perspectives. Semin Liver Dis 1986, 6: 67-81.
22. Realdi G, Alberti A, Rugge M, Rigoli AM, Tremolada F, Schivazappa L, et al. Long-term follow-up of acute and chronic non-A, non-B post-transfusion hepatitis: Evidence of progression to liver cirrhosis. Gut 1982, 23:270-275.
23. Tremolada F, Casarin C, Alberti A, Drago C, Tagger A, Ribero ML, et al. Long term follow up of non-A, non-B (type C) post-transfusion hepatitis. Hepatology 1992, 16: 273-281.